Effexor XR (venlafaxine Extended-Release) Capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 ADVERSE REACTIONS Post-Marketing Experience Dyspnea interstitial lung disease   July 2014 ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts